Open Access

Table 3

Health claims [Article 14(1)(b)] refused concerning marine lipids.

Refused
Nutrient, substance,
food or food category
Claim Reasons for rejection EFSA opinion reference Commission Regulation
Docosahexaenoic Acid (DHA)
and eicosapentaenoic acid (EPA)
contained in I omega
kids®/Pufan 3 kids®
Calming Non-compliance with the Regulation as,
on the basis of the evidence presented
in the dossier – a cause and effect
relationship between the consumption
of the food for which the claim is made
and the claimed effect has not been
established.
Q-2008-091 & Q-2008-096 Commission Regulation (EC) No 983/2009 of 21/10/2009
Provide serenity and room for
a beneficial development of the child
Q-2008-092 & Q-2008-097
Help to promote the thinking capacity Q-2008-093 & Q-2008-101
Help to promote concentration Q-2008-094 & Q-2008-099
Help to support vision Q-2008-095 & Q-2008-100
Help to support mental development Q-2008-098 & Q-2008-104
Help to support the learning ability Q-2008-102 & EFSA-Q-2008-103

Eye q baby®, containing a combination of the n-3 polyunsaturated fatty acids (PUFAs), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and the n-6 PUFA gamma-linolenic acid (GLA) Eye q baby® provides the nourishments that support healthy central nervous system development Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier – a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. Q-2008-119 Commission Regulation (EC) No 1024/2009 of 29/10/2009
Eye q® provides the nourishments that help to maintain healthy brain functions Q-2008-329
Eye q® provides the nourishment that help children to maintain concentration levels Q-2008-330

Mumomega®, containing a combination of the n-3 polyunsaturated fatty acids (PUFAs), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and the n-6 PUFA gamma-linolenic acid (GLA) Mumomega® provides the nourishments that support healthy central nervous system development Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier – a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. Q-2008-328 Commission Regulation (EC) No 1024/2009 of 29/10/2009

Docosahexaenoic Acid (DHA) and Arachidonic Acid (ARA) DHA and ARA support neural development of the brain and eyes Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier – a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. Q-2008-120 Commission Regulation (EC) No 983/2009 of 21/10/2009

Efalex® products, containing eicosapentaenoic acid (EPA), the n-6 PUFA gamma-linolenic acid (GLA) and Arachidonic Acid (ARA) Efalex® may help maintain coordination Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier – a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. Q-2008-121 Commission Regulation (EC) No 1024/2009 of 29/10/2009
Efalex® may help maintain concentration Q-2008-317
Efalex® may help maintain and support brain development and function Q-2008-318
Efalex® may help maintain learning ability Q-2008-319
Efalex® may help maintain and support eye development and function Q-2008-320

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.